Success Metrics

Clinical Success Rate
87.2%

Based on 650 completed trials

Completion Rate
87%(650/745)
Active Trials
112(10%)
Results Posted
38%(246 trials)
Terminated
95(8%)

Phase Distribution

Ph phase_3
114
10%
Ph phase_1
171
15%
Ph not_applicable
336
29%
Ph early_phase_1
39
3%
Ph phase_2
189
17%
Ph phase_4
291
25%

Phase Distribution

210

Early Stage

189

Mid Stage

405

Late Stage

Phase Distribution1140 total trials
Early Phase 1First-in-human
39(3.4%)
Phase 1Safety & dosage
171(15.0%)
Phase 2Efficacy & side effects
189(16.6%)
Phase 3Large-scale testing
114(10.0%)
Phase 4Post-market surveillance
291(25.5%)
N/ANon-phased studies
336(29.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.5%

650 of 807 finished

Non-Completion Rate

19.5%

157 ended early

Currently Active

112

trials recruiting

Total Trials

1,143

all time

Status Distribution
Active(153)
Completed(650)
Terminated(157)
Other(183)

Detailed Status

Completed650
unknown176
Terminated95
Recruiting86
Withdrawn62
Not yet recruiting33

Development Timeline

Analytics

Development Status

Total Trials
1143
Active
112
Success Rate
87.2%
Most Advanced
Phase 4

Trials by Phase

Early Phase 139 (3.4%)
Phase 1171 (15.0%)
Phase 2189 (16.6%)
Phase 3114 (10.0%)
Phase 4291 (25.5%)
N/A336 (29.5%)

Trials by Status

withdrawn625%
unknown17615%
completed65057%
terminated958%
enrolling_by_invitation81%
not_yet_recruiting333%
recruiting868%
suspended71%
active_not_recruiting262%

Recent Activity

Clinical Trials (1,143)

Showing 20 of 1,143 trialsScroll for more
NCT06096714Early Phase 1

Addictive Threshold of Nicotine

Recruiting
NCT07622355Phase 1

Effects of Different Administration Routes of Dexmedetomidine on Postoperative Sleep Quality in Patients Undergoing Thyroidectomy

Active Not Recruiting
NCT07235046Phase 2

A Study of DII235 in Adults With Elevated Lipoprotein(a)

Recruiting
NCT05477524Phase 3

An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15)

Completed
NCT07624916Phase 4

Transversus Abdominis Plane and Rectus Sheath Block for Robotic Colectomy

Not Yet Recruiting
NCT06857955Phase 2

A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients

Active Not Recruiting
NCT06023329Phase 4

Superficial Cervical Plexus Block for Improved Outcomes in Pediatric Otolaryngologic Surgery

Suspended
NCT02392442Phase 2

Effects of Bronchial Segmental Endotoxin Instillation in Humans

Enrolling By Invitation
NCT02134925Phase 2

Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon Polyps

Active Not Recruiting
NCT06932393Early Phase 1

Exosomes for Hairloss Treatment

Terminated
NCT03741478Phase 1

Intranasal Insulin and Olanzapine Study in Healthy Volunteers

Active Not Recruiting
NCT02646475Phase 1

Metabolic Effects of Angiotensin-(1-7)

Recruiting
NCT06126614Phase 3

Infection Prophylaxis in Total Joint Replacement

Recruiting
NCT06067438Phase 2

Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer

Recruiting
NCT07064993Phase 4

Effects of Intraarticular Tramadol and Tramadol-Dexamethasone on Postoperative Pain After Knee Arthroscopy

Not Yet Recruiting
NCT07295054Phase 4

3 mL Inhaled Methoxyflurane for Intrauterine Device (IUD) Insertion

Recruiting
NCT03335839Phase 3

Adjunctive, Low-dose tPA in Primary PCI for STEMI

Completed
NCT07302815Not Applicable

Preemptive Intravenous Micro-dose Dexmedetomidine to Prevent Emergence Agitation in Adult Patients Undergoing Septoplasty Surgeries

Active Not Recruiting
NCT06726577Phase 1

TP04HN106 in the Treatment of Patients With Amyotrophic Lateral Sclerosis

Recruiting
NCT04909697Phase 4

Treatment of ARDS With Sivelestat Sodium

Completed

Drug Details

Intervention Type
OTHER
Total Trials
1,143